# OnCo record paper-lch-iii-therapy-prolongation-multisystem-lch-blood-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lch-iii-therapy-prolongation-multisystem-lch-blood-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lch-iii-therapy-prolongation-multisystem-lch-blood-2013" ;
  schema:name "LCH-III: therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis"@en ;
  schema:description "Twelve months of vinblastine and prednisone, rather than six, meant fewer children's Langerhans cell histiocytosis came back, and mortality in the highest-risk children fell to a fraction of what it had been."@en ;
  schema:url <https://onco.cc/key-papers/paper-lch-iii-therapy-prolongation-multisystem-lch-blood-2013/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood-2012-09-455774>, <https://pubmed.ncbi.nlm.nih.gov/23589673/> ;
  schema:sameAs <https://doi.org/10.1182/blood-2012-09-455774> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Gadner H, Minkov M, Grois N, et al." ;
  onco:cancers <https://onco.cc/cancers/lch-single-system/>, <https://onco.cc/cancers/lch-multisystem/> ;
  onco:drugs <https://onco.cc/drugs/vinblastine/> ;
  onco:trials <https://onco.cc/trials/lch-iii/> ;
  onco:journals <https://onco.cc/journals/blood/> .
